Aptiv price target raised to $149 from $146 at Oppenheimer

Oppenheimer analyst Colin Rusch raised the firm’s price target on Aptiv to $149 from $146 and keeps an Outperform rating on the shares. Aptiv continues to execute well on controlling elements of its supply chain as industry volumes accelerate, and competition intensifies among OEMs, and is well-positioned to leverage recent acquisitions, the analyst tells investors in a research note.